• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

    3.885 +0.195 (+5.28%)
    Streaming Delayed Price Updated: 12:47 PM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Maravai LifeSciences Holdings, Inc. - Class A common stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Maravai LifeSciences Announces November 2025 Investor Conference Schedule
    From Maravai LifeSciences, Inc.
    Via Business Wire
    News headline image
    Maravai LifeSciences Reports Third Quarter 2025 Financial Results
    From Maravai LifeSciences Holdings, Inc.
    Via Business Wire
    News headline image
    MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
    From Maravai LifeSciences, Inc.
    Via Business Wire
    News headline image
    MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences Reports Second Quarter 2025 Financial Results
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
    From TriLink BioTechnologies
    Via Business Wire
    News headline image
    CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Maravai LifeSciencesReleases 2024 Sustainability Report
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
    From TriLink BioTechnologies
    Via Business Wire
    News headline image
    TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
    From TriLink BioTechnologies
    Via Business Wire
    News headline image
    Maravai Lifesciences Reports First Quarter 2025 Financial Results
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    MRVI Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Filing Deadline in Class Action Lawsuit
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    MRVI Deadline in 4 Days: Kessler Topaz Meltzer &amp; Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Filing Deadline in Class Action Lawsuit
    RADNOR, PA - May 1, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai... 
    Via TheNewswire.com
    Topics Lawsuit
    News headline image
    Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    MRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.